Catalent Expands Harmans, Maryland, Gene Therapy Campus
09/10/2020
Two state-of-the-art facilities will house a total of 15 gene therapy suites each designed to accommodate multiple bioreactors for commercial supply. The first Harmans/BWI facility on the campus was recently approved by the FDA for commercial manufacturing and is expected to have all 10 cGMP suites qualified and operational by the first quarter of 2021. The five new cGMP suites will be located in an adjacent building on the Harmans campus and are anticipated to be operational in the first half of 2022.
The Harmans campus is one of Catalent’s five gene therapy locations in Maryland and houses multiple cGMP manufacturing suites with pre-seed, bioreactor, and downstream rooms, together with fill/finish, testing, warehousing, supply chain, and central services capabilities.
“It is critical that we stay connected to the needs of our customers as they progress through the clinical pipeline. By increasing our late-stage manufacturing capacity at the Harmans campus, we will be able to meet demand through the medium term and take advantage of our shared resources, including the technical and manufacturing expertise that helped us reach the milestone of becoming an FDA-approved commercial partner,” said Manja Boerman, Ph.D., President, Cell & Gene Therapy at Catalent.
Catalent’s Harmans/BWI commercial manufacturing campus is equipped with single-use manufacturing technology, and currently includes over 200,000 square feet of late-stage clinical and commercial-stage gene therapy production. Upon outfitting of the second building, the large-scale Harmans/BWI production campus will encompass a total footprint of approximately 350,000 square feet.
Project Announcements
Hyundai Motor Group Plans Bryan County, Georgia, Electric Vehicle-Battery Plant
05/23/2022
UTAC Establishes Redford, Michigan, Operations
05/23/2022
Germany-Based Bleistahl North American Expands Battle Creek, Michigan, Operations
05/23/2022
CoinFlip Plans Tampa, Florida, Operations-Innovation Campus
05/20/2022
Catalent Expands Clark County, Kentucky, Operations
05/20/2022
Flogistix Establishes El Reno, Oklahoma, Operations
05/19/2022
Most Read
-
The Evolution of the Megasite
Q2 2022
-
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Q1 2022
-
Rail Gains Advantage Amidst Supply Chain Snarls
Q2 2022
-
The 2021 Top States for Doing Business Reflect Their Locational Advantages
Q3 2021
-
Innovative and Collaborative Design Sets the Stage for Life Science Innovation
Q2 2022
-
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2021
-
Trends in Data Center Site Selection
Q2 2022